Influence of Genetic Polymorphisms in CYP2C8 and ABCB1 on the Mobilization Ability and Toxicity of Paclitaxel

被引：0
|
作者：
Lozano, Maria L. [1 ]
Nino, Elkin A. [1 ]
Isabel Anton, Ana [2 ]
Padilla, Jose [2 ]
Rivera, Jose [2 ]
Jose Cerezo, Juan [2 ]
Castilla-Llorente, Cristina [1 ]
Garcia, Vicente [2 ]
机构：
[1] Hosp Gen Univ Morales Meseguer, Hematol & Clin Oncol Unit, Murcia, Spain
[2] Univ Murcia, Ctr Reg Hemodonac, Murcia, Spain
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [21] Genetic polymorphisms of CYP2C8 and CYP2C9 influence diurnal blood pressure parameters in elderly subjects
    Gunes, A.
    Karakucuk, E. H.
    Scordo, M. G.
    Zengil, H.
    Dahl, M. -L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 48 - 48
  • [22] Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Belmonte, Carmen
    Roman, Manuel
    Vieira de Lara, Danilo
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (04) : 522 - 531
  • [23] Influence of Abcb1 and Cyp 2c19 Polymorphisms On Rescue Therapy of Helicobacter pylori Infection
    Knauff, Laura K.
    Berning, Marco
    Kirsh, Christian
    Schneider-Brachert, Wulf
    Miehlke, Stephan
    GASTROENTEROLOGY, 2009, 136 (05) : A344 - A344
  • [24] CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population
    Saito, Yoshiro
    Katori, Noriko
    Soyama, Akiko
    Nakajima, Yukiko
    Yoshitani, Takashi
    Kim, Su-Ryang
    Fukushima-Uesaka, Hiromi
    Kurose, Kouichi
    Kaniwa, Nahoko
    Ozawa, Shogo
    Kamatani, Naoyuki
    Komamura, Kazuo
    Kamakura, Shiro
    Kitakaze, Masafumi
    Tomoike, Hitonobu
    Sugai, Kenji
    Minami, Narihiro
    Kimura, Hideo
    Goto, Yu-ichi
    Minami, Hironobu
    Yoshida, Teruhiko
    Kunitoh, Hideo
    Ohe, Yuichiro
    Yamamoto, Noboru
    Tamura, Tomohide
    Saijo, Nagahiro
    Sawada, Jun-Ichi
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (07): : 461 - 471
  • [25] Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers
    Kim, Kyoung-Ah
    Joo, Hyun-Jin
    Lee, Hae-Mi
    Park, Ji-Young
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (01): : 35 - 42
  • [26] Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
    Dai, D
    Zeldin, DC
    Blaisdell, JA
    Chanas, B
    Coulter, SJ
    Ghanayem, BI
    Goldstein, JA
    PHARMACOGENETICS, 2001, 11 (07): : 597 - 607
  • [27] Functional characterization of CYP2C8 promoter polymorphisms
    Selvarajan, V.
    EJC SUPPLEMENTS, 2009, 7 (04): : 29 - 29
  • [28] CYP2C9, CYP2C19, and ABCB1 Genotype and Hospitalization for Phenytoin Toxicity
    Hennessy, Sean
    Leonard, Charles E.
    Freeman, Cristin P.
    Metlay, Joshua P.
    Chu, Xin
    Strom, Brian L.
    Bilker, Warren B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (12): : 1483 - 1487
  • [29] CYP2C9, CYP2C19 and ABCB1 Genotype and Hospitalization for Phenytoin Toxicity
    Hennessy, Sean
    Leonard, Charles E.
    Palumbo, Cristin M.
    Metlay, Joshua P.
    Chu, Xin
    Strom, Brian L.
    Bilker, Warren B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S22 - S22
  • [30] INFLUENCE OF ABCB1 GENETIC POLYMORPHISMS ON THE PHARMACOKINETICS OF LEVOSULPIRIDE IN HEALTHY SUBJECTS
    Cho, H. Y.
    Yoo, H. D.
    Lee, Y. B.
    NEUROSCIENCE, 2010, 169 (01) : 378 - 387
12345